MedTrace Logo

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer

NCT03712774 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2018-10-19

No results posted yet for this study

Summary

Prospective observational study to evaluate the Quality of life based on standardized EORTC questionaires as well as toxicities, functional and oncological outcomes in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer.

Conditions

  • Quality of Life
  • Chemoradiation
  • Esophageal Cancer

Interventions

OTHER

EORTC QLQ C30

standardized questionaire

OTHER

EORTC QLQ OES-18

standardized questionaire

OTHER

EORTC OG-25

standardized questionaire

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Falk Roeder, MD · Ludwig-Maximilians Universität München

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-12
Primary Completion
2021-12-31
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03712774 on ClinicalTrials.gov